CD43 down-regulation during the apoptosis of PMN (polymorphonuclear cells) is not caused by proteolysis or internalization. Could it be released with bleb-derived membrane vesicles? Membrane blebbing was followed by microscopy on PMN 'synchronized' by an overnight incubation at 15
Introduction
The initial purpose of this work was to investigate the mechanism of modulation of apoptosis-dependent receptors, in particular leukosialin (CD43) and CD16 down-regulation during neutrophil apoptosis. It started from the observation that, unlike the CD43 proteolytic cleavage occurring during neutrophil activation and adhesion [1] , the decrease of CD43 expression during PMN (polymorphonuclear cells) apoptosis is not caused by proteolysis or internalization. This study was undertaken to relate the modulation of these receptors to important membrane modifications occurring in the early stages of apoptosis, i.e. phospholipids' 'flip-flop' and membrane blebbing. Indeed, we and others had observed that neutrophils with decreased CD43 or CD16 expression were those with externalized phosphatidylserine, i.e. those capable of binding annexin V [2, 3] . In addition, by analogy with ICAM-1 'secreted' with blebs from apoptotic B cells [4] , we propose that CD43 and CD16 might be released with blebs-derived membrane vesicles.
The three early membrane events of apoptosis are simultaneous
Membrane blebbing is a transient phenomenon and is hardly appreciated during neutrophils' constitutive apoptosis at 37
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to the short blebbing stage. It was thus convenient to accelerate and, to some extent, synchronize the spontaneous apoptosis of neutrophils, by preincubating PMN overnight at 15
• C before warming them at 37
• C [5] . We then analysed annexin V binding and CD43 and CD16 expression by flow cytometry. Membrane blebbing was followed by DIC (differential interference contrast) microscopy or by fluorescence microscopy after cell labelling with the membrane fluorescent probe PKH26.
The decrease of CD43 or CD16 expression and phosphatidylserine externalization occurred simultaneously after 30-45 min of incubation at 37
• C to reach a plateau of 50 ± 20% apoptotic PMN after 1.5-2 h. Membrane blebbing also started after 30 min at 37
• C to reach 50% blebbing PMN after 1 h. This number decreased after 1.5 h and was <15% blebbing cells after 2 h at 37
• C. During the blebbing stage, membrane vesicles bearing neutrophil markers (CD11b, CD16) were released in the cell supernatant and could be individualized by FSC/SSC flow cytometry analysis.
Release of membrane blebs cannot account for the decrease in CD43 expression
Time-lapse fluorescent microscopy analysis of apoptotic PMN, labelled with the membrane fluorescent probe PKH26, allowed us to follow membrane blebbing: although most of the blebbing is reversible, some bleb-derived membrane vesicles indeed detach from the cell body and could result in the loss of membrane receptors. However, the low number The PKC inhibitor staurosporin prevents phosphatidylserine externalization (expressed by annexin V binding) but not the decrease of CD43 expression during PMN apoptosis.
Figure 2 CD43 down-regulation may occur in the absence of membrane blebbing
The MLCK inhibitor ML9 does not prevent the decrease in CD43 expression during PMN apoptosis, whereas it blocks membrane blebbing and the release of bleb-derived vesicles (assessed by FSC/SSC flow cytometry).
of released blebs, observed by microscopy and quantified by flow cytometry (a mean of one released bleb per PMN), could not account for the 50 or 75% decrease in CD43 and CD16, respectively, during neutrophil apoptotis. Moreover, fluorescence and electronic microscopy observations showed that membrane blebs were not enriched in CD43 but, on the contrary, that CD43 was almost excluded from these protrusions. CD43 cells were found to be clustered at the blebs' neck, where they may participate in anchoring actomyosin fibres to the plasma membrane [6] . A similar redistribution of CD43 in myosin II-rich zones has been described in the cleavage furrow of dividing lymphocytes [7] or in the uropod of polarized PMN [8, 9] .
Signalling inhibitors allow individualization of the three membrane processes
The pan-caspase inhibitor Z-VAD-fmk significantly inhibited phosphatidylserine externalization but not membrane blebbing. Furthermore, as previously reported in other cell types [10, 11] , Z-Vad increased the number of blebbing cells. Caspase inhibition did not prevent, and even potentiated, the decrease in CD43 expression, whereas it partially prevented that of CD16. The fact that CD43 or CD16 downregulation occurred independently of phospholipids' 'flipflop' was further shown by the effect of the PKC inhibitor staurosporin. As shown in Figure 1 , staurosporin inhibited phosphatidylserine externalization, whereas it had no effect on the decrease in CD43 expression (and CD16 expression, results not shown).
Since MLCK (myosin light chain kinase) is a major kinase involved in cell blebbing [11] [12] [13] [14] , we tested the MLCK inhibitor ML9. As shown in Figure 2 , ML9 blocked the cell blebbing and the release of bleb-derived vesicles, but at the same time it did not prevent CD43 (or CD16) downregulation or phosphatidylserine externalization (results not shown).
In conclusion, the impressive membrane transformations observed during cell blebbing suggest that they could result in the release of large vesicles with loss of plasma membrane components. It may be emphasized that blebbing neutrophils, trapped in hepatic sinusoids, have been observed in vivo during experimental bacterotoxaemia and have been shown to expel blebs in the early stage of apoptosis [15] . However, we observed that apoptotic neutrophils release only a few blebderived vesicles, which could not account for the decrease in CD43 or CD16 expression. Finally, we show here that cell blebbing, phospholipids' 'flip-flop' and CD43/CD16 downregulation are simultaneous membrane events, but that each may occur independently of the other.
